FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved an original application for a fixed-dose combination of ezetimibe and simvastatin by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

ORIG AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)